GO:0008194 UDP-glycosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008194 (UDP-glycosyltransferase activity) describes the catalysis of glycosyl transfer from a UDP-sugar donor to a small hydrophobic acceptor molecule.
• Plant UGTs such as UGT89B1 and UGT73C5 use this activity to glycosylate hormones, xenobiotics and secondary metabolites, and their catalytic loops can be engineered for altered substrate specificity.
• Human UGT enzymes (UGT1A, UGT2B, UGT3A families) use UDP-glycosyltransferase activity to detoxify drugs, carcinogens and endogenous lipophilic compounds, and their expression is regulated by miRNAs.
• The same activity is exploited biotechnologically to synthesize rare ginsenosides with improved anticancer or anti-melanogenic properties.
• UDP-glycosyltransferase activity also participates in specialized pathways such as nicotine biosynthesis and sphingolipid-linked platelet autophagy.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the core tools for assigning causal roles to individual UGT genes.
Description
UDP-glycosyltransferase activity (GO:0008194) is a molecular function in which an enzyme transfers a glycosyl group from a UDP-sugar donor to a small hydrophobic acceptor molecule. This activity is widely distributed across plants, bacteria, fungi and animals, and it is responsible for converting lipophilic small molecules into more polar, often less reactive glycosides. In plants, UDP-glycosyltransferases (UGTs) modify hormones, defense compounds and xenobiotics, thereby controlling growth, development and chemical diversity. In humans, UGT enzymes perform a major phase II detoxification step for drugs, carcinogens and endogenous steroids, bile acids and bilirubin, and their expression is subject to post-transcriptional control by microRNAs. Because the reaction alters the physicochemical properties of small hydrophobic substrates, UDP-glycosyltransferase activity is central to pharmacokinetics, chemical ecology and natural-product biosynthesis. Researchers study this term to understand how organisms handle lipophilic molecules, to engineer enzymes with new substrate ranges, and to build cell and animal models that test causal roles of individual UGT genes.
UDP-glycosyltransferase activity At A Glance
| GO ID | GO:0008194 |
|---|---|
| GO term | UDP-glycosyltransferase activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Catalysis of the transfer of a glycosyl group from a UDP-sugar to a small hydrophobic molecule. |
| Major function | Glycosylation of small hydrophobic acceptors using UDP-sugar donors |
| Typical donors | UDP-glucose, UDP-galactose, UDP-glucuronic acid and related UDP-sugars |
| Representative enzymes | Plant UGTs (e.g. UGT89B1, UGT73C5), human UGT1A/UGT2B/UGT3A enzymes, bacterial UGTs |
| Research areas | Drug metabolism, xenobiotic detoxification, natural-product biosynthesis, plant hormone homeostasis, enzyme engineering |
What Is GO:0008194?
According to the Gene Ontology, GO:0008194 (UDP-glycosyltransferase activity) is defined as the catalysis of the transfer of a glycosyl group from a UDP-sugar to a small hydrophobic molecule. In practical terms, the enzyme binds a UDP-activated sugar (for example UDP-glucose) and a hydrophobic acceptor, then transfers the sugar moiety to the acceptor while releasing UDP. This definition distinguishes the term from glycosyltransferases that use other nucleotide-sugar donors or that act on large hydrophilic macromolecules.
Why Is UDP-glycosyltransferase activity Important in Cell Biology?
UDP-glycosyltransferase activity is important because it controls the fate of small hydrophobic molecules in essentially every branch of life. In humans, this activity is a major determinant of drug clearance and carcinogen activation or detoxification, and altered UGT expression or activity can change systemic exposure to therapeutic agents and environmental toxicants. In plants, the same activity regulates hormone balance, defense chemistry and the production of bioactive glycosides, making it a prime target for metabolic engineering. In biotechnology, UDP-glycosyltransferases are used to synthesize rare ginsenosides and other high-value glycosides with improved anticancer or anti-melanogenic properties. The activity also contributes to specialized processes such as nicotine biosynthesis and sphingolipid-dependent platelet autophagy, showing that its physiological reach extends beyond classical detoxification.
• Human UGT enzymes mediate phase II metabolism of drugs, carcinogens and endogenous lipophilic compounds.
• miRNA-mediated regulation of human UGT genes can alter detoxification capacity and drug response.
• Plant UGTs control hormone homeostasis, defense compounds and xenobiotic detoxification.
• Enzyme engineering of UGT loop regions can modulate catalytic activity and substrate preference.
• UDP-glycosyltransferase activity is used to produce rare ginsenosides with anticancer and anti-melanogenic activities.
• The activity participates in specialized biosynthetic pathways such as nicotine production.
• It is linked to sphingolipid metabolism and platelet autophagy in thrombosis-related biology.
• UGT3A enzymes metabolize polycyclic aromatic hydrocarbons in aerodigestive tract tissues.
• The term is a target for CRISPR-based functional genomics of detoxification and natural-product pathways.
• Understanding this activity supports drug design, toxicology and metabolic engineering applications.
Molecular Mechanism of UDP-glycosyltransferase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs a UDP-sugar donor and a small hydrophobic acceptor molecule.
UDP-glycosyltransferases bind a UDP-sugar donor, typically UDP-glucose, and a small hydrophobic acceptor in a defined active-site pocket. Plant UGTs such as UGT89B1 from radish show distinct preferences for UDP-sugar donors and acceptors, and mutations in the loop region can modulate catalytic activity. Structural and functional studies of plant UGTs have revealed that the acceptor-binding pocket and the donor-binding site cooperate to position the two substrates for catalysis. In humans, UGT enzymes of the UGT1A, UGT2B and UGT3A families recognize a wide range of lipophilic substrates, including drugs, steroids and polycyclic aromatic hydrocarbons.
Catalytic transfer of the glycosyl group
In simple terms: The enzyme moves the sugar from the UDP carrier onto the hydrophobic molecule.
Once both substrates are bound, the enzyme catalyzes the transfer of the glycosyl group from the UDP-sugar to the acceptor, releasing UDP. This reaction converts a hydrophobic molecule into a more polar glycoside, which is a central step in detoxification and natural-product biosynthesis. The catalytic mechanism depends on precise positioning of the donor and acceptor, and even small changes in the active-site loop can alter turnover and substrate specificity. In plant UGTs, this transfer step is the basis for glycosylating hormones, xenobiotics and secondary metabolites.
Product release and downstream fate
In simple terms: After the sugar is attached, the new glycoside leaves the enzyme and enters downstream pathways.
Following catalysis, the glycosylated product is released from the active site. In humans, the resulting glycosides are often more water-soluble and can be excreted, which is why UGT activity is a major clearance route for drugs and xenobiotics. In plants, the glycosylated products can serve as storage forms, defense compounds or intermediates in specialized pathways. In biotechnology, the released glycosides can be harvested as valuable natural products, as shown for rare ginsenosides synthesized by recombinant UDP-glycosyltransferases.
Regulation by miRNAs and cellular context
In simple terms: Cells can dial the activity up or down by controlling how much enzyme is made.
Human UGT genes are regulated post-transcriptionally by microRNAs, which can reduce UGT mRNA levels and thereby modulate UDP-glycosyltransferase activity. This regulation can influence drug metabolism and detoxification capacity in different tissues. In plants, UGT expression is also controlled by developmental and environmental signals, allowing the same activity to be deployed for different physiological needs. The cellular context therefore determines whether UDP-glycosyltransferase activity primarily supports detoxification, hormone homeostasis or specialized biosynthesis.
Enzyme engineering and loop-region modulation
In simple terms: Scientists can tweak the enzyme's loops to change what it glycosylates.
The loop region of plant UGTs is a hotspot for engineering catalytic activity and substrate specificity. Mutations in this region can alter the enzyme's preference for UDP-sugar donors or hydrophobic acceptors, providing a route to new glycosides. Structure-function studies of plant UGTs have guided rational design of variants with improved or altered activity. Such engineered enzymes are used to synthesize rare ginsenosides and other bioactive glycosides with potential therapeutic value.
Key Genes Involved in GO:0008194 UDP-glycosyltransferase activity
The following genes and gene families encode enzymes or regulators associated with UDP-glycosyltransferase activity across plants, bacteria and humans.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UGT89B1 | Plant UDP-glycosyltransferase from radish | Model for loop-region mutation and catalytic modulation |
| UGT73C5 | Plant UGT involved in hormone and xenobiotic glycosylation | Structure-function studies of plant UGTs |
| UGT1A family | Human phase II drug-metabolizing enzymes | Drug clearance and miRNA regulation |
| UGT2B family | Human UGTs for steroids and lipophilic substrates | Detoxification and drug metabolism |
| UGT3A family | Human UGTs metabolizing polycyclic aromatic hydrocarbons | Aerodigestive tract toxicology |
| Bacillus subtilis UGT | Bacterial UDP-glycosyltransferase | Biosynthesis of rare ginsenoside Ia |
| Recombinant UGT (ginsenoside pathway) | Engineered UGT for ginsenoside synthesis | Production of anticancer glycosides |
| Nicotine biosynthetic UGT | UGT in nicotine biosynthesis | Complete biosynthesis of nicotine |
| Sphingolipid-related UGT | UGT linked to sphingolipid metabolism | Platelet autophagy and thrombosis |
| UGT89B1 loop variants | Engineered UGT variants | Catalytic activity modulation |
| Plant UGT structural homologs | UGT fold family members | Structure-function and engineering |
| Human UGT miRNA targets | UGT genes regulated by miRNAs | Post-transcriptional control of detoxification |
| UGT1A/2B drug substrates | Enzymes acting on drugs and carcinogens | Pharmacokinetics and toxicology |
| UGT3A PAH substrates | Enzymes acting on polycyclic aromatic hydrocarbons | Aerodigestive tract metabolism |
| Ginsenoside pathway UGTs | UGTs producing rare ginsenosides | Biotechnology and anticancer activity |
| Nicotine pathway UGTs | UGTs in alkaloid biosynthesis | Plant specialized metabolism |
| Sphingolipid pathway UGTs | UGTs in sphingolipid-linked signaling | Platelet biology and thrombosis |
How Is UDP-glycosyltransferase activity Regulated?
UDP-glycosyltransferase activity is regulated at multiple levels. In humans, UGT genes are post-transcriptionally controlled by microRNAs, which can reduce UGT mRNA levels and thereby modulate enzyme activity and drug metabolism. In plants, UGT expression is controlled by developmental and environmental cues, allowing the same catalytic activity to be deployed for hormone homeostasis, defense or xenobiotic detoxification. Enzyme activity can also be tuned by structural changes in the loop region, as shown for UGT89B1, where loop mutations modulate catalytic activity. In specialized pathways, such as nicotine biosynthesis and sphingolipid-linked platelet autophagy, the activity is embedded in larger regulatory networks that control pathway flux.
UDP-glycosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UGT1A family | Drug metabolism and detoxification | Knockout and overexpression in hepatic cell lines |
| UGT3A family | Polycyclic aromatic hydrocarbon metabolism in aerodigestive tract | Knockout in airway epithelial cells |
| Ginsenoside pathway UGT | Cancer and bioactive glycoside production | Recombinant overexpression in microbial or plant cells |
| Sphingolipid-related UGT | Thrombosis and platelet autophagy | Platelet-specific knockout or knock-in models |
| Nicotine biosynthetic UGT | Plant specialized metabolism | Plant knockout and overexpression lines |
Drug metabolism and toxicology
Human UDP-glycosyltransferases are major phase II enzymes that glycosylate drugs, carcinogens and endogenous lipophilic compounds, and their expression is regulated by miRNAs. UGT3A enzymes metabolize polycyclic aromatic hydrocarbons in aerodigestive tract tissues, linking UDP-glycosyltransferase activity to toxicant handling in the upper airway and digestive tract. Altered UGT activity can therefore change systemic exposure to therapeutic agents and environmental carcinogens.
Cancer and bioactive glycosides
UDP-glycosyltransferase activity is used to synthesize rare ginsenosides with high anticancer activity, and recombinant UGT enzymes have been employed to produce these glycosides and characterize their biological properties. Rare ginsenoside Ia synthesized by a bacterial UGT showed in vitro melanogenesis inhibition in BL6B16 cells, indicating that UGT products can have cell-level bioactivities relevant to cancer and pigmentation research. These findings position UGT activity as a tool for generating therapeutic glycosides.
Thrombosis and sphingolipid metabolism
Platelet autophagic machinery involved in thrombosis has been linked to AMPK-MTOR and sphingolipid metabolism, a pathway in which UDP-glycosyltransferase activity participates through sphingolipid-related glycosylation. This connection suggests that UGT activity can influence platelet biology and thrombotic processes beyond classical drug metabolism.
Plant specialized metabolism and nicotine biosynthesis
UDP-glycosyltransferase activity contributes to the complete biosynthesis of nicotine, a specialized plant alkaloid. This example shows how UGT activity is embedded in complex biosynthetic routes that produce bioactive molecules, and it provides a model for engineering related pathways.
From UDP-glycosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate UGT gene control drug detoxification? | CRISPR knockout in human cell lines |
| How does a UGT loop mutation alter substrate specificity? | Point-mutation knock-in in plant or microbial expression systems |
| Can a UGT gene produce a specific bioactive glycoside? | Overexpression of recombinant UGT in host cells |
| Is a UGT gene required for a specialized pathway such as nicotine biosynthesis? | Plant knockout lines |
| Does a UGT gene affect platelet autophagy and thrombosis? | Platelet-specific knockout or knock-in models |
| How do miRNAs regulate UGT expression? | miRNA mimic/inhibitor experiments with UGT reporters |
How to Study the UDP-glycosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Glycosyl transfer from UDP-sugar to acceptor | Characterizing UGT89B1 and loop mutants |
| Recombinant expression | Production of active UGT enzyme | Synthesizing rare ginsenosides |
| Product analysis (e.g. LC-MS) | Identity and yield of glycosylated products | Biosynthesis of bioactive glycosides |
| miRNA manipulation | Post-transcriptional regulation of UGT genes | Studying human UGT regulation |
| Structure-function analysis | Relationship between UGT structure and activity | Engineering plant UGTs |
| Genetic knockout | Requirement of a UGT gene for a phenotype | Pathway and detoxification studies |
| Platelet functional assays | Autophagy and thrombosis-related readouts | Sphingolipid-linked UGT biology |
| Toxicology assays | Metabolism of polycyclic aromatic hydrocarbons | UGT3A function in aerodigestive tract |
Enzyme activity assays
UDP-glycosyltransferase activity can be measured using UDP-sugar donors and hydrophobic acceptors, followed by detection of glycosylated products. Such assays were used to characterize UGT89B1 from radish and to show that loop-region mutations modulate catalytic activity. Similar assays support structure-function studies of plant UGTs and their engineered variants.
Recombinant expression and product analysis
Recombinant UGT enzymes can be expressed in heterologous hosts and used to synthesize glycosides, which are then characterized by analytical chemistry. This approach was used to produce rare ginsenoside Ia from F1 by cloning and overexpressing a Bacillus subtilis UGT gene. Recombinant UGTs have also been used to biosynthesize a novel ginsenoside with high anticancer activity and to characterize its biological properties.
miRNA and gene expression analysis
Because human UGT genes are regulated by miRNAs, expression analysis combined with miRNA manipulation can reveal post-transcriptional control of UDP-glycosyltransferase activity. Such studies help link UGT mRNA levels and activity to drug metabolism phenotypes.
Pathway and cell biology studies
UDP-glycosyltransferase activity can be studied in the context of complex pathways, such as nicotine biosynthesis and sphingolipid-linked platelet autophagy. These studies combine genetic perturbation with biochemical and cell-based readouts to place UGT activity within broader physiological networks.
How CRISPR Can Be Used to Study GO:0008194 UDP-glycosyltransferase activity
Knockout
CRISPR knockout of a candidate UGT gene can test whether UDP-glycosyltransferase activity is required for detoxification, hormone homeostasis or specialized biosynthesis. For example, knocking out human UGT genes in cell lines can reveal their contribution to drug metabolism and miRNA-regulated detoxification. Plant knockout lines can test requirements in pathways such as nicotine biosynthesis.
Point Mutation
Point mutations in UGT catalytic or loop regions can modulate enzyme activity and substrate specificity, as shown for UGT89B1 where loop-region mutation altered catalytic activity. CRISPR point-mutation models allow precise testing of residues predicted to control donor or acceptor preference.
Knock-in
Knock-in of tagged or variant UGT alleles can be used to track enzyme localization, stability and interaction partners in native contexts. Such models are useful for studying UGT enzymes in complex pathways, including sphingolipid-linked platelet biology and plant specialized metabolism.
Overexpression
Overexpression of UGT genes in heterologous hosts is a standard route to produce glycosylated natural products. This approach was used to synthesize rare ginsenoside Ia from F1 with a Bacillus subtilis UGT and to biosynthesize a novel anticancer ginsenoside. Overexpression also supports enzyme engineering and structure-function studies of plant UGTs.
How EDITGENE Supports UDP-glycosyltransferase activity Research
Researchers studying UDP-glycosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic, detoxification or biosynthetic phenotype. CRISPR-based models provide a direct way to perturb UGT genes and measure the consequences on glycosylation, drug metabolism or specialized pathway output.
Contact EDITGENE today to design your custom CRISPR model for UDP-glycosyltransferase activity research.
Frequently Asked Questions About UDP-glycosyltransferase activity
What is UDP-glycosyltransferase activity?
UDP-glycosyltransferase activity (GO:0008194) is the catalysis of the transfer of a glycosyl group from a UDP-sugar to a small hydrophobic molecule.
What genes are involved in UDP-glycosyltransferase activity?
Genes include plant UGTs such as UGT89B1 and UGT73C5, human UGT1A, UGT2B and UGT3A family members, and bacterial UGTs used for ginsenoside synthesis.
What is the GO ID for UDP-glycosyltransferase activity?
The GO ID is GO:0008194.
Which ontology does GO:0008194 belong to?
GO:0008194 belongs to the molecular_function ontology.
How is UDP-glycosyltransferase activity regulated?
Human UGT genes are regulated by miRNAs, and plant UGTs are controlled by developmental and environmental signals; loop-region mutations can also modulate catalytic activity.
What diseases are linked to UDP-glycosyltransferase activity?
It is linked to drug metabolism and toxicology, cancer-related bioactive glycosides, thrombosis through sphingolipid metabolism, and plant specialized metabolism such as nicotine biosynthesis.
How can I study UDP-glycosyltransferase activity in the lab?
Common methods include enzyme activity assays, recombinant expression, product analysis, miRNA manipulation, structure-function analysis and CRISPR-based genetic models.
Can UDP-glycosyltransferases be engineered?
Yes, loop-region mutations can modulate catalytic activity, and structure-function studies guide engineering of plant UGTs for new substrates.
What products are made by UDP-glycosyltransferase activity?
Products include glycosylated drugs and xenobiotics, plant hormones and defense compounds, rare ginsenosides, nicotine pathway intermediates and sphingolipid-linked glycosides.
Why is UDP-glycosyltransferase activity important for biotechnology?
It enables the synthesis of high-value glycosides such as rare ginsenosides with anticancer or anti-melanogenic activities.
Conclusion
UDP-glycosyltransferase activity (GO:0008194) is a central molecular function that converts small hydrophobic molecules into glycosides using UDP-sugar donors. Its roles span human drug metabolism and toxicology, plant hormone and defense chemistry, and the biosynthesis of bioactive natural products such as rare ginsenosides and nicotine. Because the activity is tunable by loop-region mutations and is regulated by miRNAs and developmental signals, it is an attractive target for enzyme engineering and functional genomics. CRISPR knockout, point-mutation, knock-in and overexpression models provide direct ways to test causal roles of individual UGT genes in these pathways.
References
- 1. Ohashi H et al.. 2024. Enzymatic properties of UDP-glycosyltransferase 89B1 from radish and modulation of enzyme catalytic activity via loop region mutation.. PLoS One 19(2):e0299755 PMID: 38416725
- 2. Wang M et al.. 2023. Structure-function and engineering of plant UDP-glycosyltransferase.. Comput Struct Biotechnol J 21:5358-5371 PMID: 37965058
- 3. Chang L et al.. 2026. Complete biosynthesis of nicotine.. Cell 189(9):2700-2713.e20 PMID: 41928514
- 4. Hu DG et al.. 2022. Regulation of human UDP-glycosyltransferase (UGT) genes by miRNAs.. Drug Metab Rev 54(2):120-140 PMID: 35275773
- 5. Wang DD et al.. 2018. Rare ginsenoside Ia synthesized from F1 by cloning and overexpression of the UDP-glycosyltransferase gene from Bacillus subtilis: synthesis, characterization, and in vitro melanogenesis inhibition activity in BL6B16 cells.. J Ginseng Res 42(1):42-49 PMID: 29348721
- 6. Wang D et al.. 2025. Biosynthesis of a Novel Ginsenoside with High Anticancer Activity by Recombinant UDP-Glycosyltransferase and Characterization of Its Biological Properties.. Molecules 30(4) PMID: 40005208
- 7. Vergara AG et al.. 2020. UDP-Glycosyltransferase 3A Metabolism of Polycyclic Aromatic Hydrocarbons: Potential Importance in Aerodigestive Tract Tissues.. Drug Metab Dispos 48(3):160-168 PMID: 31836608
- 8. Lee TY et al.. 2021. Platelet autophagic machinery involved in thrombosis through a novel linkage of AMPK-MTOR to sphingolipid metabolism.. Autophagy 17(12):4141-4158 PMID: 33749503
